This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Poised for Breakouts

NxStage Medical

One stock that recently triggered a major breakout is NxStage Medical (NXTM), a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. This stock is off to a solid start in 2012, with shares up over 20%.

If you look at the chart for NxStage Medical, you'll see that this stock was sold off hard by the bears from its October high of $24.06 to a recent low of $15.42 a share. After hitting that low, the stock saw massive upside volume flow in as buyers found tremendous value. The stock then ran from $15.42 to its current price of around $21.40 a share. That run saw NXTM break out above some past overhead resistance at $20.05 to $20.13 a share on monster volume.

Traders should now watch NXTM to trigger its next big breakout once the stock moves above some near-term overhead resistance at $21.43 with volume. Look for volume on any move above that levels that registers near or above 559,600 shares. At last check the stock has hit a high today of $21.50 and volume is just over 100,000 shares traded. If we get that action, then this stock has an excellent chance to make a run at its October high of $24.06 a share, or possibly much higher.

Traders should now look for long-biased trades as long as NXTM is trending above $20 to $21.43 a share, and the upside volume is tracking in strong.

This stock also sports a very high short interest, since 11.5% of the tradable float is currently sold short by the bears. That high short interest could easily fuel a big short squeeze that spikes this stock big soon since the stock is starting to move above $21.43.

I also featured NxStage recently in " 7 Stocks Rising on Huge Volume."

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
NXTM $16.67 -0.83%
MPEL $19.21 -0.57%
TSYS $3.26 0.62%
TER $20.71 -0.43%
AAPL $132.54 0.88%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs